The JOURNAL OF PHARMACEUTICAL SCIENCES, published by ELSEVIER SCIENCE INC, stands as a cornerstone in the field of pharmaceutical sciences, offering a platform for innovative research and advancements since its inception in 1961. With an impressive Scopus Rank of #36 out of 183 in the Pharmaceutical Science category, this journal is recognized for its commitment to disseminating high-quality, peer-reviewed studies that significantly contribute to the realms of pharmacology, toxicology, and pharmaceutics. Holding a 2023 Q2 category quartile, it attracts a diverse readership encompassing researchers, industry professionals, and students eager to advance their understanding and expertise. While the journal is not open access, it ensures valuable insights in every issue, making it an essential resource for those dedicated to the evolving landscape of pharmaceutical research. With an impact factor that reflects its relevance and influence, the JOURNAL OF PHARMACEUTICAL SCIENCES continues to shape the discourse in its domain, fostering innovation and collaboration among scholars worldwide.

The Journal of Analytical Methods in Chemistry, published by HINDAWI LTD, stands as a premier platform dedicated to the dissemination of research in the vibrant field of analytical chemistry. With an ISSN of 2090-8865 and an E-ISSN of 2090-8873, this Open Access journal has been committed to providing unrestricted access to quality research since 1978, thereby fostering greater collaboration and innovation among researchers, professionals, and students globally. The journal showcases rigorous research insights spanning diverse categories, earning impressive Scopus rankings including Q2 in Chemical Engineering and Q3 in Analytical Chemistry for 2023, positioning itself effectively among respected peers. Its interdisciplinary approach also covers significant contributions in the realms of instrumentation and computer science applications, thus addressing contemporary challenges and advancements in analytical methodologies. By bridging theoretical underpinnings with practical applications, the Journal of Analytical Methods in Chemistry aims to catalyze knowledge exchange while enhancing the global discourse in analytical science.

The Journal of Pharmaceutical and Biomedical Analysis, published by ELSEVIER and available in print and online formats, stands as a pivotal source of knowledge in the realms of Analytical Chemistry, Clinical Biochemistry, Drug Discovery, and Pharmaceutical Science. With an ISSN of 0731-7085 and an e-ISSN of 1873-264X, this journal is dedicated to publishing high-quality research that advances the understanding and development of analytical techniques in pharmaceuticals and biomedicine. The journal has earned a solid reputation, reflected in its Q2 category rankings across five distinct fields for 2023, and boasts impressive Scopus rankings, signaling its robust impact within the academic community. The Journal of Pharmaceutical and Biomedical Analysis serves as an essential resource for researchers, professionals, and students alike, providing actionable insights and fostering innovation that can directly influence future advancements in drug development and biomedical applications.

JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, published by Taylor & Francis Inc, is a pivotal platform for disseminating cutting-edge research in the field of liquid chromatography and its applications across various disciplines including analytical chemistry, biochemistry, and pharmaceutical science. With an ISSN of 1082-6076 and an E-ISSN of 1520-572X, this journal serves as an essential resource for researchers, professionals, and students committed to advancing the understanding and development of chromatographic techniques. Despite not being an open access publication, the journal features a robust submission process from 1996 to 2024, ensuring comprehensive coverage of historical and contemporary methodologies. Notably, it has achieved rankings in the Q3 and Q4 quartiles across various categories, reflecting its reputable position in the field. It’s recognized within key databases, with Scopus ranks indicating its influential role in areas such as pharmaceutical science and analytical chemistry. This journal is not only a cornerstone for specialized studies but also fosters interdisciplinary collaborations, making it an invaluable asset for the scientific community.

MASS SPECTROMETRY REVIEWS, published by Wiley, is a premier academic journal dedicated to advancing the field of mass spectrometry and its applications across a multitude of scientific disciplines. With an ISSN of 0277-7037 and an E-ISSN of 1098-2787, the journal has established itself as a vital resource within the realms of Analytical Chemistry, Biochemistry, Genetics, Condensed Matter Physics, and Spectroscopy, achieving Q1 status across these categories in 2023. As a testament to its significant contribution to scholarly research, it boasts impressive Scopus rankings, including a rank of #2 out of 76 in Chemistry - Spectroscopy and #4 out of 156 in Chemistry - Analytical Chemistry, placing it in the 97th percentile and above. Emphasizing high-quality, peer-reviewed research, MASS SPECTROMETRY REVIEWS serves as an essential platform for researchers, professionals, and students aiming to stay abreast of cutting-edge developments and methodologies in mass spectrometry. The journal is committed to fostering a deeper understanding of mass spectrometric techniques while also contributing to interdisciplinary advancements, making it a valuable addition to any academic library. Authors seeking to disseminate their work in a journal with a strong reputation and impact in the scientific community will find MASS SPECTROMETRY REVIEWS an ideal venue.

PHARMAZIE is a prestigious, peer-reviewed journal published by AVOXA-MEDIENGRUPPE DEUTSCHER APOTHEKER GMBH, focusing on the dynamic field of pharmaceutical science since its inception in 1947. With its ISSN 0031-7144 and a current impact factor placing it in the Q2 category of Pharmaceutical Science journals, PHARMAZIE has established itself as a pivotal resource for researchers, practitioners, and students alike. The journal emphasizes the dissemination of high-quality, original research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of knowledge and innovation in these fields. While currently not open access, the journal maintains a commendable Scopus rank of #94 out of 183 in its category, highlighting its relevance and appeal to the academic community. With a commitment to bridging the gap between research and practical applications, PHARMAZIE plays a crucial role in shaping the future of pharmaceutical practices and policies.

LCGC North America is a pivotal resource in the field of Analytical Chemistry, published by MJH Life Sciences. Since its inception in 1999, the journal has strived to bridge the gap between scientific research and practical applications, catering to a diverse audience that includes researchers, professionals, and students interested in chromatography and related analytical practices. Although currently categorized in the Q4 quartile of Analytical Chemistry, with a Scopus rank of #137 out of 156, LCGC North America is dedicated to delivering insightful articles that foster discussion and innovation within the analytical chemistry community. With a commitment to quality content, the journal covers a broad spectrum of topics, ensuring that readers remain informed about the latest developments and trends in the field. Despite its non-open access model, readers can access its valuable resources through institutional subscriptions and various library networks, making it a vital asset for those engaged in cutting-edge research and practice. Located in Cranbury, NJ, United States, LCGC North America continues to contribute significantly to the advancement of analytical methodologies and technologies.

ELECTROPHORESIS, published by Wiley, stands as a premier journal dedicated to advancing the field of analytical chemistry, biochemistry, and clinical biochemistry. With an ISSN of 0173-0835 and an E-ISSN of 1522-2683, this journal has been a vital resource since its inception in 1980 and is poised to continue its journey through to 2024. Operating out of Germany, it holds a significant standing in the academic community, featuring in the Q2 category for Analytical Chemistry and in the Q3 tier for both Biochemistry and Clinical Biochemistry as of 2023. The journal ranks impressively within Scopus, occupying the 43rd position out of 156 in Analytical Chemistry and the 44th spot out of 117 in Clinical Biochemistry, ensuring its relevance and impact in these disciplines. Although it does not currently offer open access, ELECTROPHORESIS remains an essential publication for researchers, professionals, and students seeking cutting-edge insights and developments that influence the methodologies and technologies underpinning electrophoretic techniques.

Journal of Pharmaceutical Analysis is a premier open-access journal published by ELSEVIER, dedicated to advancing the field of pharmaceutical sciences. Since its inception in 2011, this journal has become a vital resource for researchers, professionals, and students, with a focus on analytical chemistry, drug discovery, and electrochemistry, among other subjects. With an impressive impact factor reflected in its Q1 ranking across multiple categories such as Analytical Chemistry and Drug Discovery in 2023, it maintains a high standard in the dissemination of innovative research. The journal not only facilitates the sharing of significant findings but also promotes collaboration and discussion within the community, making a notable impact globally. Articles published in the Journal of Pharmaceutical Analysis are easily accessible under an open-access model, ensuring that cutting-edge research reaches a diverse audience and enhances knowledge in this critical field. As it continues to converge research from 2011 to 2024, the journal remains a cornerstone in the study of pharmaceutical evaluation, analytical methods, and their applications.

Journal of Mass Spectrometry and Advances in the Clinical Lab, published by Elsevier, serves as a premier resource within the fields of clinical biochemistry, medical laboratory technology, microbiology, and spectroscopy. Launched in 2021 with an Open Access model, this journal enhances the accessibility of innovative research, making it an ideal platform for researchers, practitioners, and students alike. With an impressive impact factor reflected in its quartile rankings—Q2 in Clinical Biochemistry and Microbiology, and Q1 in Medical Laboratory Technology and Spectroscopy—this journal ensures high visibility and credibility. The journal's diverse indexing and significant standings in Scopus rankings highlight its commitment to advancing knowledge and fostering collaboration among professionals in laboratory sciences. Endorsed by a robust editorial board comprising leading experts, the journal aims to disseminate cutting-edge findings and methodologies, contributing to significant advancements in clinical and scientific laboratory practices. By bridging theoretical frameworks and practical applications, this journal plays a crucial role in the continuous evolution of laboratory technologies, thereby empowering readers to push the boundaries of research and innovation in their fields.